These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31322224)

  • 21. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
    Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
    Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs.
    Nogales V; Reinhold WC; Varma S; Martinez-Cardus A; Moutinho C; Moran S; Heyn H; Sebio A; Barnadas A; Pommier Y; Esteller M
    Oncotarget; 2016 Jan; 7(3):3084-97. PubMed ID: 26625211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin and epithelial ovarian cancer therapeutics.
    Patel S; Kumar L; Singh N
    Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minichromosome Maintenance Complex is Required for Checkpoint Kinase 2 Chromatin Loading and its Phosphorylation to DNA Damage Response in SCC-4 Cells.
    Li L; Feng Y; Luo R
    Protein Pept Lett; 2017; 24(3):223-228. PubMed ID: 27964702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAFF mediates PEITC-induced enhancement of sensitivity to carboplatin in ovarian cancer cell lines via activating ZNF711 transcription in vivo and invitro.
    Luan M; Zhang B; Wei Y; Liu F; Zhao Y; Yu Y; Wu Q
    Chem Biol Interact; 2024 Aug; 399():111116. PubMed ID: 38908812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of BAF57 in ovarian cancer cells and drug sensitivity.
    Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
    Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
    Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z
    Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
    Liu J; Agopiantz M; Poupon J; Wu Z; Just PA; Borghese B; Ségal-Bendirdjian E; Gauchotte G; Gompel A; Forgez P
    Clin Cancer Res; 2017 Nov; 23(21):6516-6528. PubMed ID: 28790113
    [No Abstract]   [Full Text] [Related]  

  • 29. Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells.
    Kramer D; Stark N; Schulz-Heddergott R; Erytch N; Edmunds S; Roßmann L; Bastians H; Concin N; Moll UM; Dobbelstein M
    Cell Death Differ; 2017 Feb; 24(2):300-316. PubMed ID: 27834954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between ATRIP and MCM complex is essential for ATRIP chromatin loading and its phosphorylation in mantle cell lymphoma cells.
    Nie Y; Lang T
    Pharmazie; 2017 Nov; 72(11):670-673. PubMed ID: 29442041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
    Cheung CHY; Hsu CL; Chen KP; Chong ST; Wu CH; Huang HC; Juan HF
    Sci Rep; 2017 Oct; 7(1):13302. PubMed ID: 29038488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
    Helland Ø; Popa M; Bischof K; Gjertsen BT; McCormack E; Bjørge L
    PLoS One; 2016; 11(6):e0158208. PubMed ID: 27352023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.
    Abe S; Yamamoto K; Kurata M; Abe-Suzuki S; Horii R; Akiyama F; Kitagawa M
    Oncotarget; 2015 Oct; 6(33):34892-909. PubMed ID: 26430873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
    Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
    Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
    Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
    Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin.
    van Jaarsveld MT; Blijdorp IC; Boersma AW; Pothof J; Mathijssen RH; Verweij J; Wiemer EA
    Eur J Cancer; 2013 Jan; 49(2):345-51. PubMed ID: 23041051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis.
    Lum E; Vigliotti M; Banerjee N; Cutter N; Wrzeszczynski KO; Khan S; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Gynecol Oncol; 2013 Aug; 130(2):369-76. PubMed ID: 23684582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.
    Shu T; Li Y; Wu X; Li B; Liu Z
    Cancer Lett; 2017 Dec; 411():65-73. PubMed ID: 28989055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
    Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.